Catalent | CTLT - Stock


Catalent reported $553M in Stock for its fiscal quarter ending in September of 2024.



Stock Change Date
Agilent USD 1.06B 34M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Bruker USD 1.2B 21.7M Sep/2025
Charles River Laboratories USD 299.1M 3.45M Dec/2025
Cigna USD 7.34B 1.71B Dec/2025
Danaher USD 2.49B 185M Dec/2025
Dentsply International USD 642M 44M Dec/2025
Elevance Health USD 0 0 Dec/2024
Eli Lilly USD 13.74B 1.56B Dec/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Hologic USD 688.5M 9.1M Dec/2025
Illumina USD 564M 26M Dec/2025
Intuitive Surgical USD 1.84B 58.1M Dec/2025
J&J USD 14.19B 45M Dec/2025
Laboratory Of America USD 534.7M 13.2M Dec/2025
Lonza CHF 1.68B 163M Dec/2025
McKesson USD 27.07B 933M Dec/2025
Merck EUR 4.51B 42M Sep/2025
Merck USD 6.44B 157M Sep/2025
Mettler Toledo International USD 387.23M 14.58M Dec/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Quest Diagnostics USD 189M 3M Dec/2025
Repligen USD 170.46M 10.14M Dec/2025
Revvity USD 379.5M 420K Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
UnitedHealth USD 280M 280M Dec/2023
Waters USD 572.37M 570K Dec/2025
West Pharmaceutical Services USD 443.9M 5.9M Dec/2025